{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:12Z","timestamp":1792787832543,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Basic Science Research Program","award":["NRF-2017R1E1A1A01074298"],"award-info":[{"award-number":["NRF-2017R1E1A1A01074298"]}]},{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2016-076"],"award-info":[{"award-number":["2016-076"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We hypothesized that portal vein tumor thrombosis (PVTT) in hepatocellular carcinoma (HCC) increases portal pressure and causes esophageal varices and variceal bleedings. We examined the incidence of high-risk varices and variceal bleeding and determined the indications for variceal screening and prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included 1709 asymptomatic patients without any prior history of variceal hemorrhage or endoscopic prophylaxis who underwent upper endoscopy within 30\u2009days before or after initial anti-HCC treatment. Of these patients, 206 had PVTT, and after 1:2 individual matching, 161 of them were matched with 309 patients without PVTT. High-risk varices were defined as large\/medium varices or small varices with red-color signs and variceal bleeding. Bleeding rates from the varices were compared between matched pairs. Risk factors for variceal bleeding in the entire set of patients with PVTT were also explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the matched-pair analysis, the proportion of high-risk varices at screening (23.0% vs. 13.3%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003) and the cumulative rate of variceal bleeding (4.5% vs. 0.4% at 1\u2009year;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.009) were significantly greater in the PVTT group. Prolonged prothrombin time, lower platelet count, presence of extrahepatic metastasis, and Vp4 PVTT were independent risk factors related to high-risk varices in the total set of 206 patients with PVTT (Adjusted odds ratios [95% CIs], 1.662 [1.151\u20132.401]; 0.985 [0.978\u20130.993]; 4.240 [1.783\u201310.084]; and 3.345 [1.457\u20137.680], respectively; Ps\u2009&lt;\u20090.05). During a median follow-up of 43.2\u2009months, 10 patients with PVTT experienced variceal bleeding episodes, 9 of whom (90%) had high-risk varices. Presence of high-risk varices and sorafenib use for HCC treatment were significant predictors of variceal bleeding in the complete set of patients with PVTT (Adjusted hazard ratios [95% CIs], 26.432 [3.230\u2013216.289]; and 5.676 [1.273\u201325.300], respectively; Ps\u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PVTT in HCC appears to increase the likelihood of high-risk varices and variceal bleeding. In HCC patients with PVTT, endoscopic prevention could be considered, at least in high-risk variceal carriers taking sorafenib.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07708-1","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T09:03:48Z","timestamp":1609837428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Variceal bleeding is aggravated by portal venous invasion of hepatocellular carcinoma: a matched nested case-control study"],"prefix":"10.1186","volume":"21","author":[{"given":"Jihye","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihyun","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seheon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Ok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han chu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung Sang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7336-1371","authenticated-orcid":false,"given":"Ju Hyun","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"7708_CR1","doi-asserted-by":"crossref","unstructured":"Couto OF, Dvorchik I, Carr BI. Causes of death in patients with unresectable hepatocellular carcinoma. Dig Dis Sci 2007;52(11):3285\u20133289. Epub 2007\/04\/17.","DOI":"10.1007\/s10620-007-9750-3"},{"key":"7708_CR2","doi-asserted-by":"crossref","unstructured":"Hsieh WY, Chen PH, Lin IY, Su CW, Chao Y, Huo TI, et al. The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinoma. Sci Rep 2017;7:42577. Epub 2017\/02\/18.","DOI":"10.1038\/srep42577"},{"key":"7708_CR3","doi-asserted-by":"crossref","unstructured":"D'Avola D, Inarrairaegui M, Pardo F, Rotellar F, Marti P, Bilbao JI, et al. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages. Ann Surg Oncol 2011;18(7):1964\u20131971. Epub 2011\/01\/27.","DOI":"10.1245\/s10434-011-1551-4"},{"key":"7708_CR4","doi-asserted-by":"crossref","unstructured":"Jackson FW, Adrain AL, Black M, Miller LS. Calculation of esophageal variceal wall tension by direct sonographic and manometric measurements. Gastrointest Endosc 1999;50(2):247\u2013251. Epub 1999\/07\/30.","DOI":"10.1016\/S0016-5107(99)70233-6"},{"key":"7708_CR5","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018;69(2):406\u2013460. Epub 2018\/04\/15.","DOI":"10.1016\/j.jhep.2018.08.009"},{"issue":"6","key":"7708_CR6","first-page":"9021","volume":"9","author":"JZ Ye","year":"2016","unstructured":"Ye JZ, Ye HH, Xie S, Duan WL, Bai T, Chen J, et al. Indications and treatment of hepatocellular carcinoma with portal vein tumor thrombus based on two classifications. Int J Clin Exp Med. 2016;9(6):9021\u201332.","journal-title":"Int J Clin Exp Med"},{"key":"7708_CR7","doi-asserted-by":"crossref","unstructured":"Sinn DH, Cho JY, Gwak GY, Paik YH, Choi MS, Lee JH, et al. Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread. PLoS One 2015;10(4):e0124434. Epub 2015\/04\/30.","DOI":"10.1371\/journal.pone.0124434"},{"key":"7708_CR8","doi-asserted-by":"crossref","unstructured":"Yeh JL, Peng YC, Tung CF, Chen GH, Chow WK, Chang CS, et al. Clinical predictors of large esophagogastric varices in patients with hepatocellular carcinoma. Dig Dis Sci 2002;47(4):723\u2013729. Epub 2002\/05\/07.","DOI":"10.1023\/A:1014719428637"},{"key":"7708_CR9","doi-asserted-by":"crossref","unstructured":"Kadouchi K, Higuchi K, Shiba M, Okazaki H, Yamamori K, Sasaki E, et al. What are the risk factors for aggravation of esophageal varices in patients with hepatocellular carcinoma? J Gastroenterol Hepatol 2007;22(2):240\u2013246. Epub 2007\/02\/14.","DOI":"10.1111\/j.1440-1746.2006.04418.x"},{"issue":"6","key":"7708_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.clinre.2015.02.012","volume":"39","author":"X Qi","year":"2015","unstructured":"Qi X, Su C, Ren W, Yang M, Jia J, Dai J, et al. Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: a systematic review of the literature. Clin Res Hepatol Gastroenterol. 2015;39(6):683\u201391.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"7708_CR11","doi-asserted-by":"crossref","unstructured":"Augustin S, Pons M, Maurice JB, Bureau C, Stefanescu H, Ney M, et al. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology. 2017;66(6):1980\u20131988. Epub 2017\/07\/12.","DOI":"10.1002\/hep.29363"},{"key":"7708_CR12","doi-asserted-by":"crossref","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American association for the study of liver diseases. Hepatology. 2017;65(1):310\u2013335. Epub 2016\/10\/28.","DOI":"10.1002\/hep.28906"},{"key":"7708_CR13","doi-asserted-by":"crossref","unstructured":"Giannini EG, Risso D, Testa R, Trevisani F, Di Nolfo MA, Del Poggio P, et al. Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 2006;4(11):1378\u20131384. Epub 2006\/10\/25.","DOI":"10.1016\/j.cgh.2006.08.011"},{"key":"7708_CR14","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2018;69(1):182\u2013236. Epub 2018\/04\/10."},{"key":"7708_CR15","doi-asserted-by":"crossref","unstructured":"Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723\u2013750. Epub 2018\/04\/07.","DOI":"10.1002\/hep.29913"},{"key":"7708_CR16","doi-asserted-by":"crossref","unstructured":"Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int 2017;11(4):317\u2013370. Epub 2017\/06\/18.","DOI":"10.1007\/s12072-017-9799-9"},{"key":"7708_CR17","doi-asserted-by":"crossref","unstructured":"Sarin SK, Kumar A, Angus PW, Baijal SS, Chawla YK, Dhiman RK, et al. Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the liver. Hepatol Int 2008;2(4):429\u2013439. Epub 2009\/08\/12.","DOI":"10.1007\/s12072-008-9096-8"},{"key":"7708_CR18","doi-asserted-by":"crossref","unstructured":"Ryu HJ, Kim WS, Lee JH, Min SW, Kim SJ, Lee YS, et al. Asan medical information system for healthcare quality improvement. Healthc Inform Res 2010;16(3):191\u2013197. Epub 2011\/08\/06.","DOI":"10.4258\/hir.2010.16.3.191"},{"key":"7708_CR19","doi-asserted-by":"crossref","unstructured":"Lerose R, Molinari R, Rocchi E, Manenti F, Villa E. Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease. Eur J Cancer 2001;37(2):239\u2013245. Epub 2001\/02\/13.","DOI":"10.1016\/S0959-8049(00)00354-3"},{"key":"7708_CR20","doi-asserted-by":"crossref","unstructured":"Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis. Gastroenterology. 2019;156(6):1582\u20131599 e1. Epub 2019\/02\/17.","DOI":"10.1053\/j.gastro.2019.01.265"},{"key":"7708_CR21","doi-asserted-by":"crossref","unstructured":"Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 2000;32(5):865\u2013871. Epub 2000\/06\/14.","DOI":"10.1016\/S0168-8278(00)80259-7"},{"key":"7708_CR22","doi-asserted-by":"crossref","unstructured":"Parikh S, Shah R, Kapoor P. Portal vein thrombosis. Am J Med 2010;123(2):111\u2013119. Epub 2010\/01\/28.","DOI":"10.1016\/j.amjmed.2009.05.023"},{"issue":"4","key":"7708_CR23","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/hep.22758","volume":"49","author":"M Mejias","year":"2009","unstructured":"Mejias M, Garcia-Pras E, Tiani C, Miquel R, Bosch J, Fernandez M. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology. 2009;49(4):1245\u201356.","journal-title":"Hepatology."},{"issue":"4","key":"7708_CR24","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/liv.12299","volume":"34","author":"Y-Y Yang","year":"2014","unstructured":"Yang Y-Y, Liu R-S, Lee P-C, Yeh Y-C, Huang Y-T, Lee W-P, et al. Anti-VEGFR agents ameliorate hepatic venous dysregulation\/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat. Liver Int. 2014;34(4):521\u201334.","journal-title":"Liver Int"},{"issue":"2","key":"7708_CR25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1476-5381.2009.00158.x","volume":"157","author":"M Hennenberg","year":"2009","unstructured":"Hennenberg M, Trebicka J, Stark C, Kohistani AZ, Heller J, Sauerbruch T. Sorafenib targets dysregulated rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis. Br J Pharmacol. 2009;157(2):258\u201370.","journal-title":"Br J Pharmacol"},{"key":"7708_CR26","doi-asserted-by":"crossref","unstructured":"Duffy A, Wilkerson J, Greten TF. Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapies. Hepatology. 2013;57(3):1068\u20131077. Epub 2012\/11\/01.","DOI":"10.1002\/hep.26120"},{"issue":"1","key":"7708_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3350\/cmh.2017.0064","volume":"24","author":"YS Seo","year":"2018","unstructured":"Seo YS. Prevention and management of gastroesophageal varices. Clin Mol Hepatol. 2018;24(1):20.","journal-title":"Clin Mol Hepatol"},{"key":"7708_CR28","doi-asserted-by":"crossref","unstructured":"Garcia-Pagan JC, De Gottardi A, Bosch J. Review article: the modern management of portal hypertension--primary and secondary prophylaxis of variceal bleeding in cirrhotic patients. Aliment Pharmacol Ther 2008;28(2):178\u2013186. Epub 2008\/05\/09.","DOI":"10.1111\/j.1365-2036.2008.03729.x"},{"key":"7708_CR29","doi-asserted-by":"crossref","unstructured":"Dai C, Zhou F, Shao JH, Wu LQ, Yu X, Yin XB. Bleeding risk in cancer patients treated with sorafenib: a meta-analysis of randomized controlled trials. J Cancer Res Ther 2018;14(12):948\u2013956. Epub 2018\/12\/13.","DOI":"10.4103\/0973-1482.188430"},{"key":"7708_CR30","doi-asserted-by":"crossref","unstructured":"Yoon SM, Lim YS, Won HJ, Kim JH, Kim KM, Lee HC, et al. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. Int J Radiat Oncol Biol Phys 2012;82(5):2004\u20132011. Epub 2011\/05\/31.","DOI":"10.1016\/j.ijrobp.2011.03.019"},{"key":"7708_CR31","doi-asserted-by":"crossref","unstructured":"Lang BH, Poon RT, Fan ST, Wong J. Outcomes of patients with hepatocellular carcinoma presenting with variceal bleeding. Am J Gastroenterol 2004;99(11):2158\u20132165. Epub 2004\/11\/24.","DOI":"10.1111\/j.1572-0241.2004.40336.x"},{"key":"7708_CR32","doi-asserted-by":"crossref","unstructured":"Merkel C, Zoli M, Siringo S, van Buuren H, Magalotti D, Angeli P, et al. Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the north Italian endoscopic Club (NIEC) index. Am J Gastroenterol 2000;95(10):2915\u20132920. Epub 2000\/10\/29.","DOI":"10.1111\/j.1572-0241.2000.03204.x"},{"key":"7708_CR33","doi-asserted-by":"crossref","unstructured":"Kim JH, Sinn DH, Kim K, Kang W, Gwak GY, Paik YH, et al. Primary prophylaxis for variceal bleeding and the improved survival of patients with newly diagnosed hepatocellular carcinoma. Dig Dis Sci 2016;61(11):3354\u20133362. Epub 2016\/10\/19.","DOI":"10.1007\/s10620-016-4255-6"},{"key":"7708_CR34","doi-asserted-by":"crossref","unstructured":"Chen PH, Chen WC, Hou MC, Liu TT, Chang CJ, Liao WC, et al. Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: a cohort study. J Hepatol 2012;57(6):1207\u20131213. Epub 2012\/08\/14.","DOI":"10.1016\/j.jhep.2012.07.038"},{"key":"7708_CR35","doi-asserted-by":"crossref","unstructured":"Hsu YC, Chung CS, Tseng CH, Lin TL, Liou JM, Wu MS, et al. Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage. J Gastroenterol Hepatol 2009;24(7):1294\u20131299. Epub 2009\/08\/18.","DOI":"10.1111\/j.1440-1746.2009.05903.x"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07708-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-07708-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07708-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T20:04:23Z","timestamp":1609877063000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07708-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["7708"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07708-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"18 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study protocol was approved by the Ethics Committee of Asan Medical Center (IRB No. 2019\u20130545), and this study was conducted in accordance with the Declaration of Helsinki. Because this study is based on the retrospective analysis of existing clinical data, the requirement of obtaining informed patient consent was waived by the Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no underlying conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}